DA Scheinberg

2.5k total citations
34 papers, 2.0k citations indexed

About

DA Scheinberg is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology and Molecular Biology. According to data from OpenAlex, DA Scheinberg has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Hematology and 11 papers in Molecular Biology. Recurrent topics in DA Scheinberg's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Acute Myeloid Leukemia Research (6 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). DA Scheinberg is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Acute Myeloid Leukemia Research (6 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). DA Scheinberg collaborates with scholars based in United States. DA Scheinberg's co-authors include RP Jr Warrell, Ethan Dmitrovsky, Young Cw, Josephia R. Muindi, SR Frankel, Ann A. Jakubowski, Monica Bocchia, Alessandro Sette, P. Maslak and Glenn Heller and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

DA Scheinberg

34 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DA Scheinberg United States 18 1.1k 916 476 460 452 34 2.0k
Dario Ferrero Italy 25 872 0.8× 1.0k 1.1× 472 1.0× 93 0.2× 338 0.7× 92 2.0k
Gabriel Ghiaur United States 25 934 0.9× 725 0.8× 479 1.0× 43 0.1× 413 0.9× 87 1.9k
S A Cannistra United States 11 816 0.8× 333 0.4× 644 1.4× 82 0.2× 502 1.1× 11 2.4k
W. E. Berdel Germany 19 546 0.5× 383 0.4× 445 0.9× 50 0.1× 240 0.5× 49 1.3k
Fumihiko Hayakawa Japan 26 1.4k 1.3× 1.1k 1.2× 624 1.3× 21 0.0× 303 0.7× 85 2.4k
Yukiya Yamamoto Japan 15 834 0.8× 1.2k 1.3× 257 0.5× 34 0.1× 211 0.5× 36 1.8k
Evdoxia Hatjiharissi United States 21 724 0.7× 727 0.8× 649 1.4× 207 0.5× 555 1.2× 86 2.0k
Emanuele Ammatuna Netherlands 19 850 0.8× 770 0.8× 228 0.5× 32 0.1× 206 0.5× 63 1.6k
Michaël Sébag Canada 23 1.0k 1.0× 801 0.9× 766 1.6× 255 0.6× 187 0.4× 115 1.8k
Salmon Se United States 16 474 0.4× 300 0.3× 422 0.9× 108 0.2× 102 0.2× 34 1.0k

Countries citing papers authored by DA Scheinberg

Since Specialization
Citations

This map shows the geographic impact of DA Scheinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DA Scheinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DA Scheinberg more than expected).

Fields of papers citing papers by DA Scheinberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DA Scheinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DA Scheinberg. The network helps show where DA Scheinberg may publish in the future.

Co-authorship network of co-authors of DA Scheinberg

This figure shows the co-authorship network connecting the top 25 collaborators of DA Scheinberg. A scholar is included among the top collaborators of DA Scheinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DA Scheinberg. DA Scheinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jurcic, Joseph G., Todd Rosenblat, Michael R. McDevitt, et al.. (2013). Targeted Alpha-particle Nano-generator Actinium-225 (225Ac)-lintuzumab (anti-CD33) in Acute Myeloid Leukemia (AML). Clinical Lymphoma Myeloma & Leukemia. 13. S379–S380. 11 indexed citations
2.
3.
Heffner, Leonard T., Nicole Lamanna, M Kalaycio, et al.. (2005). A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL. Journal of Clinical Oncology. 23(16_suppl). 6516–6516. 7 indexed citations
4.
Ma, Dangshe, et al.. (2002). Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies. Leukemia. 16(1). 60–66. 39 indexed citations
5.
6.
Nikula, Tuomo, Michael R. McDevitt, Ronald D. Finn, et al.. (1999). Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.. PubMed. 40(1). 166–76. 156 indexed citations
7.
8.
Bocchia, Monica, Tatyana Korontsvit, Qin Xu, et al.. (1996). Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood. 87(9). 3587–3592. 231 indexed citations
9.
Maslak, P., et al.. (1995). Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.. PubMed. 9(2). 244–8. 33 indexed citations
10.
Jurcic, Joseph G., Esperanza B. Papadopoulos, Stephen Mackinnon, et al.. (1994). 131I-LABELED M195 FOR MYELOID LEUKEMIAS. Journal of Immunotherapy. 16(2). 161–161. 2 indexed citations
11.
Nikula, Tuomo, R.D. Finn, Otto A. Gansow, et al.. (1994). Alpha particle emitting constructs of recomblnant humanized antl-CD33 for myelold teukemlas. Journal of Immunotherapy. 16(2). 149–149. 1 indexed citations
12.
Maslak, P., et al.. (1993). CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia [letter; comment] [see comments]. Blood. 81(6). 1666–1666. 9 indexed citations
13.
Maslak, P., W. H. Miller, Gerwin Heller, et al.. (1993). CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia [letter; comment] [see comments]. Blood. 81(6). 1666–1666. 9 indexed citations
14.
Bajorin, Dean F., Paul B. Chapman, George Y. Wong, et al.. (1992). Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma. Melanoma Research. 2(5). 355–362. 35 indexed citations
15.
16.
17.
Lemoli, Roberto M., Cristina Gasparetto, DA Scheinberg, et al.. (1991). Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. Blood. 77(8). 1829–1836. 2 indexed citations
18.
Scheinberg, DA, et al.. (1991). Monoclonal antibody therapy for cancer.. PubMed. 12. 147–63. 1 indexed citations
19.
Tanimoto, Mitsune, et al.. (1989). Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.. PubMed. 3(5). 339–48. 80 indexed citations
20.
Scheinberg, DA, et al.. (1986). Monoclonal antibodies: potential applications to the treatment of cancer.. PubMed. 13(2). 165–79. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dario Ferrero Breakdown of academic impact, for papers by Gabriel Ghiaur Breakdown of academic impact, for papers by S A Cannistra Breakdown of academic impact, for papers by W. E. Berdel Breakdown of academic impact, for papers by Fumihiko Hayakawa Breakdown of academic impact, for papers by Yukiya Yamamoto Breakdown of academic impact, for papers by Evdoxia Hatjiharissi Breakdown of academic impact, for papers by Emanuele Ammatuna Breakdown of academic impact, for papers by Michaël Sébag Breakdown of academic impact, for papers by Salmon Se
Rankless by CCL
2026